Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
F. Njau, N. Shushakova, H. Schenk, V. C. Wulfmeyer, R. Bollin, J. Menne, H. Haller
This study shows calcium dobesilate inhibits VEGF signaling by blocking heparan sulfate binding, reducing vascular complications in diabetic mice.
bioRxiv · Jun 5, 2019Cell Biology